SecBot SecBot
8-K ·Filed Aug 4, 2026

DVA

DAVITA INC.
BULLISH
Impact 6/10
Horizonweeks Processed3mo ago SEC0000927066-26-000105
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The modest EPS and revenue beat combined with maintained guidance supports a constructive view. The aggressive share repurchase program ($348M in Q2) continues to drive EPS accretion. Monitor the Q3 earnings call for any impact from the new Term Loan B-2 on interest expense and leverage, and for updates on normalized treatment growth trends.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$187.61
T+0 close · Aug 4, 2026 · via day close
Latest settled
+3.04%
T+60 · $193.31
Vs SPY
+3.10%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 5 $187.61entry
  2. T+1 · 3mo ago −4.07%α −3.91% · $179.97
  3. T+5 · 3mo ago −3.26%α −3.61% · $181.50
  4. T+20 · 3mo ago −4.68%α −4.08% · $178.83
  5. T+60 · 19d ago +3.04%α +3.10% · $193.31
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

DaVita reported Q2 2026 diluted EPS of $4.02 on consolidated revenues of $3.554B. The EPS beat the Street consensus of $4.01 by a marginal 0.25%, while revenue exceeded the $3.49B estimate by 1.8%. The company maintained its full-year 2026 guidance for adjusted operating income ($2.15B-$2.25B) and adjusted diluted EPS ($14.10-$15.20), signaling confidence in operational momentum despite a slight sequential decline in revenue per treatment.

Key Financial Metrics

EPS
$4.02
est $4.01 · +0.3%
Revenue
$3.6B
est $3.5B · +1.8% · +5.2% YoY
Rating
beat
Free Cash Flow
$256.0M

Key Facts

  • Q2 2026 diluted EPS of $4.02 vs consensus $4.01 (beat by 0.25%)
  • Q2 2026 consolidated revenues of $3.554B vs consensus $3.49B (beat by 1.8%)
  • Revenue grew 5.2% YoY from $3.380B in Q2 2025
  • Operating income of $579M (16.3% margin) vs $538M (15.9%) in Q2 2025
  • Full-year 2026 guidance maintained: adjusted operating income $2.15B-$2.25B, adjusted diluted EPS $14.10-$15.20
  • Repurchased 2.2M shares for $348M in Q2; additional 0.2M shares for $37M post-quarter
  • Incurred $500M incremental Term Loan B-2 tranche in June 2026

Financial Impact

Q2 EPS beat by $0.01 (0.25%) and revenue beat by $64M (1.8%) vs consensus; guidance unchanged

epsrevenueoperating incomeshare repurchasesdebt

Risk Factors

  • Slight sequential decline in revenue per treatment ($415.87 vs $417.59 in Q1 2026)
  • Leverage ratio increased to 3.37x from 3.34x in Q1 2026 due to new debt
  • Dependence on commercial payor mix and potential downward pressure on rates
  • Normalized non-acquired treatment growth remains low at 0.3% YoY

Market Snapshot

Exchange
NYSE
Sector
Services-Misc Health & Allied Services, NEC
Analyst Consensus
46% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000927066-26-000105
Document: dva-20260804.htm0000927066-26-000105
Document: 0000927066-26-000105-index-headers.html0000927066-26-000105
Document: 0000927066-26-000105-index.html0000927066-26-000105
Document: 0000927066-26-000105.txt0000927066-26-000105
8-K Data (Synthetic)0000927066-26-000105

Track record

9 reports on DVA

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Oct 29, 202618d ago 8-K Mixed 5/10 No price data
  2. Oct 29, 202618d ago Press Release Bullish 6/10 Entry $187.50 Now $174.22 −7.08% settles Jan 28
  3. Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $183.64 Now $174.22 −5.13% settles Jan 21
  4. Aug 4, 202614w ago 8-K Bullish 6/10 Viewing Entry $187.61 to $193.31 Now $174.22 −7.14% ▲ +3.04% +3.10% vs SPY
  5. Jun 15, 202622w ago Court Ruling Neutral 1/10 Entry $208.98 to $181.55 Now $174.22 −16.63% ▼ −13.13% −14.99% vs SPY
  6. Jun 8, 202623w ago 8-K Mixed 5/10 Entry $198.19 to $178.83 Now $174.22 −12.09% ▼ −9.77% −13.58% vs SPY
  7. May 18, 202626w ago Insider Cluster Neutral 3/10 Entry $194.38 to $179.17 Now $174.22 −10.37% ▼ −7.82% −13.84% vs SPY
  8. May 13, 202626w ago Insider Cluster Bearish 6/10 Entry $192.30 to $183.48 Now $174.22 +9.40% ▲ +4.59% +7.91% vs SPY
  9. May 5, 202627w ago 8-K Bullish 8/10 Entry $191.76 to $238.86 Now $174.22 −9.15% ▲ +24.56% +23.49% vs SPY
Showing 9 of 9

US Market Status

Market Closed · Opens Wed (11h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 4, 2026